BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 19250907)

  • 1. Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage.
    Mahmoudi S; Henriksson S; Corcoran M; Méndez-Vidal C; Wiman KG; Farnebo M
    Mol Cell; 2009 Feb; 33(4):462-71. PubMed ID: 19250907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wrap53, a novel regulator of p53.
    Farnebo M
    Cell Cycle; 2009 Aug; 8(15):2343-6. PubMed ID: 19571673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin induces apoptosis via upregulating Wrap53 in U-2OS osteosarcoma cells.
    Yuan JM; Li XD; Liu ZY; Hou GQ; Kang JH; Huang DY; Du SX
    Asian Pac J Cancer Prev; 2011; 12(12):3465-9. PubMed ID: 22471498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CTCF regulates the human p53 gene through direct interaction with its natural antisense transcript, Wrap53.
    Saldaña-Meyer R; González-Buendía E; Guerrero G; Narendra V; Bonasio R; Recillas-Targa F; Reinberg D
    Genes Dev; 2014 Apr; 28(7):723-34. PubMed ID: 24696455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlapping region of p53/wrap53 transcripts: mutational analysis and sequence similarity with microRNA-4732-5p.
    Pouladi N; Kouhsari SM; Feizi MH; Gavgani RR; Azarfam P
    Asian Pac J Cancer Prev; 2013; 14(6):3503-7. PubMed ID: 23886136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of WRAP53 transcript variants on non-small cell lung cancer cell behaviors.
    Zhu Y; Sun W; Jiang X; Bai R; Luo Y; Gao Y; Li S; Huang Z; Gong Y; Xie C
    PLoS One; 2023; 18(1):e0281132. PubMed ID: 36706151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WRAP53 promotes cancer cell survival and is a potential target for cancer therapy.
    Mahmoudi S; Henriksson S; Farnebo L; Roberg K; Farnebo M
    Cell Death Dis; 2011 Jan; 2(1):e114. PubMed ID: 21368886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional and epigenetic regulation of the p53 tumor suppressor gene.
    Saldaña-Meyer R; Recillas-Targa F
    Epigenetics; 2011 Sep; 6(9):1068-77. PubMed ID: 21814038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of
    Yao YF; Liu W; Zhou ML; Qiu TL; Wang K
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 May; 53(3):457-465. PubMed ID: 35642155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear WRAP53 promotes neuronal survival and functional recovery after stroke.
    Sánchez-Morán I; Rodríguez C; Lapresa R; Agulla J; Sobrino T; Castillo J; Bolaños JP; Almeida A
    Sci Adv; 2020 Oct; 6(41):. PubMed ID: 33028529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic Activity of Wrap53 in Human Colorectal Cancer In Vitro and in Nude Mouse Xenografts.
    Zhu Y; Ding L; Chen BF; Song JG; Yao YS
    Med Sci Monit; 2018 Sep; 24():6129-6136. PubMed ID: 30175821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells.
    Gan L; Yang XL; Liu Q; Xu HB
    J Cell Biochem; 2005 Oct; 96(3):653-64. PubMed ID: 16088946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anthracyclines induce the accumulation of mutant p53 through E2F1-dependent and -independent mechanisms.
    Bug M; Dobbelstein M
    Oncogene; 2011 Aug; 30(33):3612-24. PubMed ID: 21441950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity.
    Kim EJ; Kho JH; Kang MR; Um SJ
    Mol Cell; 2007 Oct; 28(2):277-90. PubMed ID: 17964266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bidirectional p53-Wrap53β promoter is controlled by common cis- and trans-regulatory elements.
    Polson A; Reisman D
    Gene; 2014 Mar; 538(1):138-49. PubMed ID: 24418698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype and linkage disequilibrium of TP53-WRAP53 locus in Iranian-Azeri women with breast cancer.
    Pouladi N; Abdolahi S; Farajzadeh D; Hosseinpour Feizi MA
    PLoS One; 2019; 14(8):e0220727. PubMed ID: 31387111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenoviral expression of p53 represses telomerase activity through down-regulation of human telomerase reverse transcriptase transcription.
    Kanaya T; Kyo S; Hamada K; Takakura M; Kitagawa Y; Harada H; Inoue M
    Clin Cancer Res; 2000 Apr; 6(4):1239-47. PubMed ID: 10778946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53.
    Blattner C; Sparks A; Lane D
    Mol Cell Biol; 1999 May; 19(5):3704-13. PubMed ID: 10207094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense RNA and p53 regulation in induced murine cell differentiation.
    Khochbin S; Brocard MP; Grunwald D; Lawrence JJ
    Ann N Y Acad Sci; 1992 Oct; 660():77-87. PubMed ID: 1340159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-mediated control of gene expression via mRNA translation during Endoplasmic Reticulum stress.
    López I; Tournillon AS; Nylander K; Fåhraeus R
    Cell Cycle; 2015; 14(21):3373-8. PubMed ID: 26397130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.